Markets
Instil Bio, Inc. (TIL)
TILNASDAQ-CMBiotechnology: Biological Products (No Diagnostic Substances)
$6.35
-0.1200 (-1.85%) today
At the close, Nov 10, 4:00 PM ET. After hours $6.40 +0.79%
-1.85% 1D
- Market cap
- $43.07m
- P/E
- –
- EPS, last 4 quarters
- –
- Dividend yield
- –
- Day range
- $6.34 to $6.86
- 52-week range
- $5.56 to $16.00
- Average volume
- 36.5k
- Previous close
- $6.47
Earnings
Next report Nov 12, 2026
Financials
| Quarter | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | – | – | – | – |
| Gross profit | – | – | – | – |
| Operating income | -$15.02m | -$9.56m | -$7.01m | -$5.58m |
| Net income | -$13.59m | -$8.19m | -$4.20m | -$4.30m |
News
8 latest- Instil Bio (TIL) Price Target Increased by 24.53% to 67.32Fintel · Apr 8, 2026
- Instil Bio (TIL) Price Target Increased by 41.50% to 97.66Fintel · Oct 29, 2025
- Instil Bio Posts Wider Loss in Q2The Motley Fool · Aug 13, 2025
- Instil Bio Announces Clearance Of AXN-2510 IND RTTNews · Jul 2, 2025
- Instil Bio Announces FDA Clearance for IND of AXN-2510, Phase 1 Trial Expected by End of 2025Quiver Quantitative · Jul 2, 2025
- Instil Bio, Inc. (TIL) Is Up 4.07% in One Week: What You Should Know Zacks · Jun 20, 2025
- Wall Street Analysts Think Instil Bio (TIL) Could Surge 246.68%: Read This Before Placing a BetZacks · Jun 16, 2025
- Instil Bio Appoints John Maraganore, Ph.D., to Board of Axion Bio to Advance Development of AXN-2510Quiver Quantitative · Jun 11, 2025
The company
Instil Bio, Inc. is a biotechnology company focused on identifying and advancing innovative therapeutics.
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Exchange
- NASDAQ-CM
- Region
- North America
- Website
- instilbio.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.